Cardiovascular Diseases, Cerebrovascular Diseases, Respiratory Diseases
Conditions
Keywords
prevention, treatment strategies, respiratory diseases, cardiovascular diseases, cerebrovascular diseases
Brief summary
Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, to evaluate the therapeutic effect of Pulmonary rehabilitation exercise and usual care for three months. And finally, to build a trinity model of rehabilitation management of COPD patients. The objective of this project is to establish and promote the application of diagnostic and treatment norms.
Detailed description
Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person),CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function of the two groups of patients one year after the intervention. And finally, to build a trinity model of rehabilitation management of COPD patients.
Interventions
participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person),CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function of the two groups of patients one year after the intervention.
participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person),CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function one year after the intervention.
Sponsors
Study design
Intervention model description
Firstly, to screen out the high-risk population of COPD combined with cardiovascular and cerebrovascular diseases, COPD with cardiovascular and make a diagnosis. Then, participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person),CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function of the two groups of patients one year after the intervention. And finally, to build a trinity model of rehabilitation management of COPD patients.
Eligibility
Inclusion criteria
1. Committed to adhering to the study protocol and cooperating with the implementation of the entire research process. 2. Aged 18 years or older, regardless of gender. 3. Signed informed consent form.
Exclusion criteria
1. Individuals with severe mental illness. 2. Individuals assessed by medical personnel as having a disease that requires immediate hospitalization or a severe, uncontrollable condition that is life-threatening in the short term. 3. Women who are pregnant, breastfeeding, or using inappropriate contraception methods. 4. Individuals who refuse to cooperate with follow-up questionnaires or specimen collection. 5. Patients currently participating in other interventional clinical drug trials.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The proportion of high-risk and diagnosed individuals with COPD | through study completion, an average of 4 year | We conducted a cross-sectional screening among a total of 50,000 people, and then calculated the proportion of the high-risk and confirmed COPD patients among the total population. We use COPD questionnaire to screen COPD high-risk groups and make a diagnosis of COPD through pulmonary function test. |
| the improvement of acute exacerbation frequency (times/year/person) | through study completion, an average of 4 year | Observe the changes in the improvement of acute exacerbation frequency (times/year/person) after intervention |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| FBG(fasting blood-glucose) | through study completion, an average of 4 year | The risk of chronic cardiovascular and cerebrovascular diseases was evaluated. based on a comprehensive assessment of the patient's blood pressure, blood sugar, blood lipids, etc.,All measurements were conducted in accordance with international standards and units(mmol/L) |
| blood lipids | through study completion, an average of 4 year | The risk of chronic cardiovascular and cerebrovascular diseases was evaluated. based on a comprehensive assessment of the patient's blood pressure, blood sugar, blood lipids, etc.,All measurements were conducted in accordance with international standards and units(mmol/L). |
| Blood pressure | through study completion, an average of 4 year | Based on a comprehensive assessment of the patient's blood pressure, blood sugar, blood lipids, etc., the risk of chronic cardiovascular and cerebrovascular diseases was evaluated. All measurements were conducted in accordance with international standards and units (mmHg) |
Other
| Measure | Time frame | Description |
|---|---|---|
| Observe the changes of SGRQ | through study completion, an average of 4 year | Observe the changes in the improvement of acute exacerbation frequency (times/year/person) after intervention. |
| Observe the changes in CAT Scoring | through study completion, an average of 4 year | Observe the changes in CAT Scoring after intervention |
Countries
China